Apollomics, Inc. (NASDAQ:APLMW) Sees Significant Decrease in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 17,400 shares, a drop of 6.5% from the August 31st total of 18,600 shares. Based on an average daily volume of 20,500 shares, the days-to-cover ratio is presently 0.8 days.

Apollomics Price Performance

APLMW opened at $0.01 on Wednesday. Apollomics has a 12-month low of $0.01 and a 12-month high of $0.10. The stock’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.02.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.